Idexx Laboratories's market cap is currently ―. The company's EPS TTM is $10.063; its P/E ratio is 49.46; Idexx Laboratories is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $2.70. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 915.53M	$ 943.63M	$ 900.20M	$ 828.57M	$ 841.66M
Gross Profit	$ 737.00M	$ 943.63M	$ 542.97M	$ 484.93M	$ 506.63M
EBIT	$ 276.54M	$ 296.47M	$ 280.81M	$ 226.53M	$ 245.18M
EBITDA	$ 305.52M	$ 324.33M	$ 309.15M	$ 255.25M	$ 273.73M
Net Income Common Stockholders	$ 212.23M	$ 224.24M	$ 214.05M	$ 172.21M	$ 180.94M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 331.70M	$ 132.84M	$ 111.37M	$ 112.55M	$ 99.18M
Total Assets	$ 3.09B	$ 2.87B	$ 2.81B	$ 2.75B	$ 2.64B
Total Debt	$ 1.12B	$ 1.13B	$ 1.30B	$ 1.45B	$ 1.51B
Net Debt	$ 788.58M	$ 1.00B	$ 1.19B	$ 1.34B	$ 1.41B
Total Liabilities	$ 1.79B	$ 1.78B	$ 1.97B	$ 2.75B	$ 2.16B
Stockholders Equity	$ 1.30B	$ 1.09B	$ 841.10M	$ 608.74M	$ 476.00M
Cash Flow	-
Free Cash Flow	$ 238.34M	$ 172.84M	$ 144.40M	$ 124.20M	$ 151.31M
Operating Cash Flow	$ 272.43M	$ 200.31M	$ 183.91M	$ 173.43M	$ 189.00M
Investing Cash Flow	$ -27.84M	$ -27.47M	$ -39.51M	$ -49.23M	$ -49.20M
Financing Cash Flow	$ -43.04M	$ -151.03M	$ -146.08M	$ -116.72M	$ -148.83M

Currency in USD

Idexx Laboratories Earnings and Revenue History

Income Statement >

Idexx Laboratories Debt to Assets

Balance Sheet >

Idexx Laboratories Cash Flow

Cash Flow >

Idexx Laboratories Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing